After icodec rejection, Novo Nordisk plots 2024 FDA filing for once-weekly insulin and semaglutide combo fkansteiner Mon, 08/12/2024 – 15:27 More: After icodec rejection, Novo Nordisk plots 2024 FDA filing for once-weekly insulin and semaglutide combo Source: fierce
read moreDaxxify maker Revance agrees to $924M buyout by private skin care company Crown Laboratories fkansteiner Mon, 08/12/2024 – 14:38 More: Daxxify maker Revance agrees to 4M buyout by private skin care company Crown Laboratories Source: fierce
read moreAscendis scores hard-fought FDA nod for hormone replacement therapy Yorvipath kdunleavy Mon, 08/12/2024 – 10:41 More: Ascendis scores hard-fought FDA nod for hormone replacement therapy Yorvipath Source: fierce
read morePfizer, looking to expand RSV vaccine’s reach, touts its benefits in immunocompromised adults aliu Mon, 08/12/2024 – 09:39 More: Pfizer, looking to expand RSV vaccine's reach, touts its benefits in immunocompromised adults Source: fierce
read moreAjinomoto will lay off 71 staffers in CA to streamline CDMO business following $620M Forge Biologics buy fkansteiner Mon, 08/12/2024 – 08:27 More: Ajinomoto will lay off 71 staffers in CA to streamline CDMO business following 0M Forge Biologics buy
read more
Bowel cancer was the most common cancer to be identified in both men and women More: UCL study reveals routine blood tests could improve early cancer diagnosis Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals